Back to results
US 2022/0033508 A1Published application
Anti-il13r alpha2 antibodies
AssigneeAdc Therapeutics SA
InventorsPatricius Hendrikus Cornelis Van Berkel, Francois Bertelli
Life of this patent
Estimating the term…
Abstract
This disclosure relates to antibodies that specifically bind to the Interleukin-13 receptor subunit alpha-2 (IL13Rα2) protein, and associated uses and methods for production.
Claims22
An antibody that binds to Interleukin-13 receptor subunit alpha-2 (IL13Rα2), which comprises a heavy chain variable region comprising the amino acid sequence of SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.